UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 10.376

Sortiert nach

Human papillomavirus (HPV) vaccine utilization among adults (18–29 years), BRFSS 2015

Vaccine, 2020-07, Vol.38 (33), p.5119-5122

2020

Link zum Volltext

Verfügbarkeit prüfen

Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey—Adult 2007

Preventive medicine, 2009-05, Vol.48 (5), p.426-431

2009

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine in Healthy Boys Aged 10–18 Years

Journal of adolescent health, 2009, Vol.44 (1), p.33-40

2009

Link zum Volltext

Verfügbarkeit prüfen

Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States—Do we need a broader vaccine policy?

Vaccine, 2013-11, Vol.31 (47), p.5500-5505

Osazuwa-Peters, N

2013

Link zum Volltext

Verfügbarkeit prüfen

Community-based household assessment of human papillomavirus (HPV) vaccination coverage and acceptability – HPV vaccine demonstration program, Cambodia – 2017

Vaccine, 2019-02, Vol.37 (9), p.1202-1208

2019

Link zum Volltext

Verfügbarkeit prüfen

Human Papillomavirus (HPV) Infection in Squamous Cell Carcinomas Arising From the Oropharynx: Detection of HPV DNA and p16 Immunohistochemistry as Diagnostic and Prognostic Indicators—A Pilot Study

International journal of radiation oncology, biology, physics, 2014-08, Vol.89 (5), p.1115-1120

2014

Link zum Volltext

Verfügbarkeit prüfen

Wild-type p53 reactivation by small-molecule Minnelide™ in human papillomavirus (HPV)-positive head and neck squamous cell carcinoma

Oral oncology, 2014-12, Vol.50 (12), p.1149-1156

2014

Link zum Volltext

Verfügbarkeit prüfen

Does pretreatment human papillomavirus (HPV) titers predict radiation response and survival outcomes in cancer cervix?—A pilot study

Gynecologic oncology, 2006-10, Vol.103 (1), p.100-105

2006

Link zum Volltext

Verfügbarkeit prüfen

Human papillomavirus (HPV) in pregnancy – An update

European journal of obstetrics & gynecology and reproductive biology, 2021-09, Vol.264, p.340-348

2021

Link zum Volltext

Verfügbarkeit prüfen

“Saving lives”: Adapting and adopting Human Papilloma Virus (HPV) vaccination in Austria

Social science & medicine (1982), 2016-03, Vol.153, p.193-200

Paul, Katharina T.

2016

Link zum Volltext

Verfügbarkeit prüfen

Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study

Journal of clinical virology, 2022-09, Vol.154, p.105237-105237, Article 105237

2022

Link zum Volltext

Verfügbarkeit prüfen

Tanzania’s human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019

Vaccine, 2022-03, Vol.40 (Suppl 1), p.A38-A48

2022

Link zum Volltext

Verfügbarkeit prüfen

Healthcare professional’s promotional strategies in improving Human papillomavirus (HPV) vaccination uptake in adolescents: A systematic review

Vaccine, 2022-04, Vol.40 (19), p.2656-2666

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of the human papillomavirus (HPV) vaccine supply shortage on Tanzania’s national HPV vaccine introduction

Vaccine, 2022-03, Vol.40, p.A26-A29

2022

Link zum Volltext

Verfügbarkeit prüfen

Reported adverse events in girls aged 13–16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands

Vaccine, 2011-06, Vol.29 (28), p.4601-4607

2011

Link zum Volltext

Verfügbarkeit prüfen

Human papillomavirus (HPV) vaccine introduction in Sikkim state: Best practices from the first statewide multiple-age cohort HPV vaccine introduction in India–2018–2019

Vaccine, 2022-03, Vol.40 (Suppl 1), p.A17-A25

2022

Link zum Volltext

Verfügbarkeit prüfen

Human papillomavirus (HPV) vaccine and HPV-related head and neck cancer: What’s next?

Oral oncology, 2019-06, Vol.93, p.125-126

2019

Link zum Volltext

Verfügbarkeit prüfen

Assessing university students’ sexual risk behaviors as predictors of human papillomavirus (HPV) vaccine uptake behavior

Vaccine, 2018-06, Vol.36 (25), p.3629-3634

2018

Link zum Volltext

Verfügbarkeit prüfen

Optimization of human papillomavirus (HPV) type 16 E7-expressing lactobacillus-based vaccine for induction of mucosal E7-specific IFNγ-producing cells

Vaccine, 2018-06, Vol.36 (24), p.3423-3426

2018

Link zum Volltext

Verfügbarkeit prüfen

30-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-escalation trials (MC1273 & MC1675)

Oral oncology, 2023-02, Vol.137, p.106248-106248, Article 106248

2023

Link zum Volltext

Verfügbarkeit prüfen

A single serum dilution enzyme-linked immunosorbent assay for determining anti-human papillomavirus (HPV) antibody titres in humans immunised with prophylactic HPV vaccines

Journal of pharmaceutical and biomedical analysis, 2012-07, Vol.66, p.352-355

2012

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of type-specific antibodies to high risk-human papillomavirus (HPV) proteins in patients with oropharyngeal cancer

Oral oncology, 2017-07, Vol.70, p.43-50

2017

Link zum Volltext

Verfügbarkeit prüfen

Performance of the Roche AMPLICOR® Human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear

Gynecologic oncology, 2005-10, Vol.99 (1), p.160-168

2005

Link zum Volltext

Verfügbarkeit prüfen

Early impact of Ontario’s human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): A population-based assessment

Vaccine, 2016-09, Vol.34 (39), p.4678-4683

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 10.376

Suche als RSS-Feed

Aktive Filter

KollektionNexis Uni

KollektionSingle Journals

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(10.227)
Mit Volltextzugriff
(10.306)

Publikationsform

Artikel
(10.365)
Reviews
(9)
Bücher
(2)

Sprache

Englisch
(10.337)
Japanisch
(1.045)
Französisch
(46)
Norwegisch
(3)
Spanisch
(3)
Russisch
(3)

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(8.575)
Life Sciences & Biomedicine
(8.487)
Humans
(7.582)
Female
(5.374)
Human Papillomavirus
(3.894)
Adult
(2.582)
Oncology
(2.576)
Biological And Medical Sciences
(2.370)
Cervical Cancer
(2.176)
Middle Aged
(2.154)
Immunology
(2.061)
Vaccines
(1.893)
Medicine, Research & Experimental
(1.756)
Research & Experimental Medicine
(1.756)
Virology
(1.717)
Male
(1.699)
Medical Sciences
(1.698)
Hematology, Oncology And Palliative Medicine
(1.625)
Obstetrics & Gynecology
(1.568)
Hpv
(1.431)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Human papillomavirus (HPV) vaccine utilization among adults (18–29 years), BRFSS 2015

Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey—Adult 2007

Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine in Healthy Boys Aged 10–18 Years

Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States—Do we need a broader vaccine policy?

Community-based household assessment of human papillomavirus (HPV) vaccination coverage and acceptability – HPV vaccine demonstration program, Cambodia – 2017

Human Papillomavirus (HPV) Infection in Squamous Cell Carcinomas Arising From the Oropharynx: Detection of HPV DNA and p16 Immunohistochemistry as Diagnostic and Prognostic Indicators—A Pilot Study

Wild-type p53 reactivation by small-molecule Minnelide™ in human papillomavirus (HPV)-positive head and neck squamous cell carcinoma

Does pretreatment human papillomavirus (HPV) titers predict radiation response and survival outcomes in cancer cervix?—A pilot study

Human papillomavirus (HPV) in pregnancy – An update

“Saving lives”: Adapting and adopting Human Papilloma Virus (HPV) vaccination in Austria

Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study

Tanzania’s human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019

Healthcare professional’s promotional strategies in improving Human papillomavirus (HPV) vaccination uptake in adolescents: A systematic review

Impact of the human papillomavirus (HPV) vaccine supply shortage on Tanzania’s national HPV vaccine introduction

Reported adverse events in girls aged 13–16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands

Human papillomavirus (HPV) vaccine introduction in Sikkim state: Best practices from the first statewide multiple-age cohort HPV vaccine introduction in India–2018–2019

Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021—March 2022

Human papillomavirus (HPV) vaccine and HPV-related head and neck cancer: What’s next?

Assessing university students’ sexual risk behaviors as predictors of human papillomavirus (HPV) vaccine uptake behavior

Optimization of human papillomavirus (HPV) type 16 E7-expressing lactobacillus-based vaccine for induction of mucosal E7-specific IFNγ-producing cells

30-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-escalation trials (MC1273 & MC1675)

A single serum dilution enzyme-linked immunosorbent assay for determining anti-human papillomavirus (HPV) antibody titres in humans immunised with prophylactic HPV vaccines

Evaluation of type-specific antibodies to high risk-human papillomavirus (HPV) proteins in patients with oropharyngeal cancer

Performance of the Roche AMPLICOR® Human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear

Early impact of Ontario’s human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): A population-based assessment

Aktive Filter

Suchergebnisse filtern